RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Robert Kirken to Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Back to Details
This is a "connection" page, showing publications Robert Kirken has written about Precursor T-Cell Lymphoblastic Leukemia-Lymphoma.
Robert Kirken
Connection Strength
0.105
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
  1. Ross JA, Spadaro M, Rosado DC, Cavallo F, Kirken RA, Pericle F. Inhibition of JAK3 with a novel, selective and orally active small molecule induces therapeutic response in T-cell malignancies. Leukemia. 2014 Apr; 28(4):941-4.
    View in: PubMed
    Score: 0.105
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support